Business Intelligence Center

You are here: Home : White Papers : Accounting : Tax : Abstract

Stock Options For Life Science Companies

Sponsored By Burr Pilger Mayer

Topics:: Accounting > Tax; Compliance & Governance; Professional Services

View White Paper now

Free registration is required

Abstract:: It's a popular practice to issue stock options to employees, particularly for early-stage tech and biotech companies. However, Management should be aware of possible financial consequences if the proper compliance procedures are not followed. In this white paper we'll discuss:

- Accounting rules adopted in 2005, regarding compensatory option grants, that can significantly impact a company�s financial processes and result in severe penalties if not implemented properly.
- The key to ensuring that the options are priced accurately, which means the business and underlying security value must be adequately supported and documented. This differs for public and privately-held companies.
- Different option pricing models that FASB will accept, as long as they meet certain criteria and are appropriate to the interest being valued.

DETAILS

Sponsored by: Burr Pilger Mayer

Released: March 02, 2010

Length: 11 pages

Format: PDF (3360 kb)

Email this abstract

These white papers are not created by the CFO.com editorial staff. In order to view these papers, you must register with CFO.com and agree to share your contact information with related product/service companies.